Patent details

Basic Information

Publication number:

EP2948134

PCT Application Number:

US2014013066

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147431233

PCT Publication Number:

WO2014117035

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS FOR TRANSDERMAL DELIVERY OF MTOR INHIBITORS

French Title of Invention:

COMPOSITIONS POUR UNE ADMINISTRATION TRANSDERMIQUE D'INHIBITEURS DE MTOR

German Title of Invention:

ZUSAMMENSETZUNGEN ZUR TRANSDERMALEN VERABREICHUNG VON MTOR-INHIBITOREN

SPC Number:

Dates

Filing date:

15/03/2013

Grant date:

04/03/2020

EP Publication Date:

02/12/2015

PCT Publication Date:

31/07/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/03/2020

EP B1 Publication Date:

04/03/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/01/2021

Expiration date:

24/01/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/02/2020

 

 

Name:

Palvella Therapeutics, Inc.

Address:

125 Strafford Avenue, Suite 360, Wayne, Pennsylvania 19087, United States (US)

Inventor

1

Name:

SPEAKER, Tycho

Address:

United States (US)

2

Name:

KASPAR, Roger L.

Address:

United States (US)

Priority

Priority Number:

201361756406 P

Priority Date:

24/01/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/70; A61K 31/436; C07D 491/00;

Publication

European Patent Bulletin

Issue number:

202010

Publication date:

04/03/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages